Category: Fujifilm Medical Systems U.S.A. Inc.
Nine prominent medical device companies sign on to a pledge to increase the interoperability of their products in the interest of patient safety.
Nine medical device companies ranging from industry titans to small-cap movers inked a pledge to make the data generated by their devices available to patients, in a move aimed at ridding the healthcare system of unnecessary deaths by 2020.
Beacon Endoscopic partners with Fujifilm to distribute Beacon’s endoscopic ultrasound devices in select markets outside the U.S.
Newton, Mass.-based endoscopic startup Beacon Endoscopic signed a strategic partnership in order distribute its 2nd product internationally through Fujifilm Holdings (TSE:4901), the companies announced.
Mauna Kea Technologies receives regulatory approval in China for its Cellvizio confocal endomicroscopy device and lands a partnership with Fujifilm China to develop the market there.
The China State Food & Drug Administration approved Mauna Kea Technologies' Cellvizio confocal endomicroscopy system, a device design to see cancer faster.
Despite a lethargic economy, medical device companies boosted their spending on research & development last year, according to MassDevice.com's Big 100 database of the 100 largest med-tech makers.
Across the medical device industry, R&D spending in 2011 increased despite a lethargic economy, job cuts and reorganization mandates by a number of big-name companies.
Coming off of an accounting scandal that cut the company's assets by nearly 30%, Olympus may look to raise investor confidence through strategic alliances.
MASSDEVICE ON CALL — A post-scandal Olympus (PINK:OCPNY) is considering strategic alliances to boost investor confidence, having received at least 3 offers from potential partners.
GMI Ratings, which rates companies according to how risky it is to invest in them, puts Boston Scientific on its Risk List; also, BD: No need for "transformative" acquisitions; Dow adds Medtronic to Dividend 100 list; Zeltiq inks amended distribution deal for Mexico; DexCom hits its SweetSpot; Syneron closes Ultrashape deal; Varian Medical to pay $15M for InfiMed; GPOs: KCI, AGFA Healthcare, Carestream Health, Fujifilm USA, Konica Minolta ink Novation supply deals; plus a Funding Roundup and analysts' ups and downs.
A rating agency specializing in evaluating risky investments added Boston Scientific (NYSE:BSX) to its "Risk List," citing the ongoing fallout from its ill-starred Guidant buyout, its accounting and governance practices and how it pays its executives.
